SATO Establishes SATO Healthcare Australia
New subsidiary to consolidate healthcare business
Sydney, Australia, August 07, 2015 --(PR.com)-- SATO (TSE:6287), a leading global provider of Auto-ID solutions that empower workforces and streamline operations today announced the establishment of SATO Healthcare Australia Pty Ltd.
With the acquisition of Magellan Technology in 2013, the SATO Group nearly tripled its healthcare segment revenue in Australia The newly established SATO Healthcare Australia will consolidate the healthcare business of the SATO Group in Australia. It will particularly focus on serving healthcare accounts in Australia and patient safety solutions featuring Auto-ID technology and the unique PJM RFID Technology to meet the needs of the growing1 healthcare market.
In 2014, SATO established SATO Healthcare Co., Ltd. in Tokyo, as a spin-off from SATO Corporation, to support special demands for Auto-ID solutions in the medical field and globally leverage its expertise and knowledge-base of tracking goods using Auto-ID technology. SATO Healthcare has been rapidly capturing market share in the medical sector since, especially with its core business—patient safety solutions—utilizing its unique PJM RFID technology. The unit has reported approximately 48% growth of revenue in the global healthcare segment since inception.
“Our healthcare expertise has been completely customer driven as we aim to become the leader in patient safety solutions worldwide,” said Hiroyuki Konuma, President of SATO Healthcare Co., Ltd. “The establishment of SATO Healthcare in Japan has resulted in successful business results for one reason – our commitment to the healthcare segment being well received by customers’ actual experience of our enhanced services and offerings. I am confident that SATO Healthcare Australia will achieve the same.”
“Our increased presence in Australia demonstrates the SATO commitment to our customers there,” said Kaz Matsuyama, President and CEO of SATO Holdings Corporation. “We have over 100 accounts with major hospitals and suppliers of medical devices, pharmaceuticals and medical supplies in Australia today. We will increasingly tailor our business for the Australia healthcare segment as we reinvest profit and customize services to meet the needs of customers.”
The newly established SATO Healthcare Australia Pty Ltd is located at 8 Guihen Street, Annandale, Sydney.
About SATO
SATO (TSE:6287) is a leading global provider of Auto-ID solutions that connect people, goods and information. It serves a diverse range of customers, delivering end-to-end solutions that streamline operations, empower workforces and help customers reduce their environmental impact. For the fiscal year ended March 31, 2015, it reported revenues of JPY 99,831 million (US$ 910 million*). More information about SATO can be found at www.satoworldwide.com or www.linkedin.com/company/sato-worldwide.
*Conversion is based on an average exchange rate of 1 US Dollar = 109.75 Japanese Yen.
With the acquisition of Magellan Technology in 2013, the SATO Group nearly tripled its healthcare segment revenue in Australia The newly established SATO Healthcare Australia will consolidate the healthcare business of the SATO Group in Australia. It will particularly focus on serving healthcare accounts in Australia and patient safety solutions featuring Auto-ID technology and the unique PJM RFID Technology to meet the needs of the growing1 healthcare market.
In 2014, SATO established SATO Healthcare Co., Ltd. in Tokyo, as a spin-off from SATO Corporation, to support special demands for Auto-ID solutions in the medical field and globally leverage its expertise and knowledge-base of tracking goods using Auto-ID technology. SATO Healthcare has been rapidly capturing market share in the medical sector since, especially with its core business—patient safety solutions—utilizing its unique PJM RFID technology. The unit has reported approximately 48% growth of revenue in the global healthcare segment since inception.
“Our healthcare expertise has been completely customer driven as we aim to become the leader in patient safety solutions worldwide,” said Hiroyuki Konuma, President of SATO Healthcare Co., Ltd. “The establishment of SATO Healthcare in Japan has resulted in successful business results for one reason – our commitment to the healthcare segment being well received by customers’ actual experience of our enhanced services and offerings. I am confident that SATO Healthcare Australia will achieve the same.”
“Our increased presence in Australia demonstrates the SATO commitment to our customers there,” said Kaz Matsuyama, President and CEO of SATO Holdings Corporation. “We have over 100 accounts with major hospitals and suppliers of medical devices, pharmaceuticals and medical supplies in Australia today. We will increasingly tailor our business for the Australia healthcare segment as we reinvest profit and customize services to meet the needs of customers.”
The newly established SATO Healthcare Australia Pty Ltd is located at 8 Guihen Street, Annandale, Sydney.
About SATO
SATO (TSE:6287) is a leading global provider of Auto-ID solutions that connect people, goods and information. It serves a diverse range of customers, delivering end-to-end solutions that streamline operations, empower workforces and help customers reduce their environmental impact. For the fiscal year ended March 31, 2015, it reported revenues of JPY 99,831 million (US$ 910 million*). More information about SATO can be found at www.satoworldwide.com or www.linkedin.com/company/sato-worldwide.
*Conversion is based on an average exchange rate of 1 US Dollar = 109.75 Japanese Yen.
Contact
SATO Holdings Corporation
Kevin Leidheiser
+81-3-5745-3412
www.satoworldwide.com
Kevin Leidheiser
+81-3-5745-3412
www.satoworldwide.com
Contact
Categories